Johnson Chemical Pharmaceutical Works Co., Ltd. (4747.TWO)

TWD 67.2

(-0.44%)

Operating Income Summary of Johnson Chemical Pharmaceutical Works Co., Ltd.

  • Johnson Chemical Pharmaceutical Works Co., Ltd.'s latest annual operating income in 2023 was 105.57 Million TWD , up 26.47% from previous year.
  • Johnson Chemical Pharmaceutical Works Co., Ltd.'s latest quarterly operating income in 2024 Q2 was 28.58 Million TWD , down -6.45% from previous quarter.
  • Johnson Chemical Pharmaceutical Works Co., Ltd. reported an annual operating income of 83.47 Million TWD in 2022, up 32.46% from previous year.
  • Johnson Chemical Pharmaceutical Works Co., Ltd. reported an annual operating income of 63.01 Million TWD in 2021, down -18.02% from previous year.
  • Johnson Chemical Pharmaceutical Works Co., Ltd. reported a quarterly operating income of 26.51 Million TWD for 2024 Q1, up 15.18% from previous quarter.
  • Johnson Chemical Pharmaceutical Works Co., Ltd. reported a quarterly operating income of 23.01 Million TWD for 2023 Q4, down -6.35% from previous quarter.

Annual Operating Income Chart of Johnson Chemical Pharmaceutical Works Co., Ltd. (2023 - 2019)

Historical Annual Operating Income of Johnson Chemical Pharmaceutical Works Co., Ltd. (2023 - 2019)

Year Operating Income Operating Income Growth
2023 105.57 Million TWD 26.47%
2022 83.47 Million TWD 32.46%
2021 63.01 Million TWD -18.02%
2020 76.86 Million TWD -2.49%
2019 78.83 Million TWD 0.0%

Peer Operating Income Comparison of Johnson Chemical Pharmaceutical Works Co., Ltd.

Name Operating Income Operating Income Difference
Allied Biotech Corporation 88.71 Million TWD -19.002%
GeneFerm Biotechnology Co., Ltd. 153.56 Million TWD 31.253%
Easywell Biomedicals, Inc. -162.73 Million TWD 164.872%
TTY Biopharm Company Limited 1.37 Billion TWD 92.308%
Synmosa Biopharma Corporation 614.74 Million TWD 82.827%
Orient EuroPharma Co., Ltd. 84.55 Million TWD -24.856%
Center Laboratories, Inc. -79.26 Million TWD 233.187%
Tien Liang BioTech Co., Ltd. 20.43 Million TWD -416.593%
Orient Pharma Co., Ltd. 27.75 Million TWD -280.395%
InnoPharmax Inc. -64.83 Million TWD 262.82%
Excelsior Biopharma Inc. -81.12 Million TWD 230.129%
DV Biomed Co., Ltd. 173.54 Million TWD 39.169%
Foresee Pharmaceuticals Co., Ltd. -1 Billion TWD 110.477%
Handa Pharmaceuticals, Inc. 695.79 Million TWD 84.827%
UniPharma Co., Ltd. -27.3 Million TWD 486.636%
Anxo Pharmaceutical Co., Ltd. 53.15 Million TWD -98.617%
Alar Pharmaceuticals Inc. 385.52 Million TWD 72.616%
Winston Medical Supply Co., Ltd. 196.1 Million TWD 46.165%
Mercury Biopharmaceutical Corporation -45.69 Million TWD 331.059%
Bioray Biotech Co., Ltd -19.33 Million TWD 646.123%
TSH Biopharm Corporation Limited 63.63 Million TWD -65.914%